Wiley Bros. Aintree Capital, LLC Dexcom Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 9,517 shares of DXCM stock, worth $661,336. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,517Holding current value
$661,336% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,111Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.23 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.4 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.13 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.06 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$830 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $26.8B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...